首页行业分类生物医药生物2023-05-06-中泰证券-智飞生物-收入符合预期,常规疫苗实现良好开局
PDF

2023-05-06-中泰证券-智飞生物-收入符合预期,常规疫苗实现良好开局

无**车5页760.52K

下载文档
/5
全屏查看
2023-05-06-中泰证券-智飞生物-收入符合预期,常规疫苗实现良好开局
还有 5 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 5 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
R中泰证券ZHONGTAI SECURITIES公司点评12000200%180%10000160%140%8000120%6000100%80%400060%40%200020%00%营业收入营业成本销售费用管理费用研发费用所得税2022018,841.155,864.04362.6872.07160.897.03340.221,922.7620230111,172.777,787.06446.7579.85213.9619.60360.262,032.0226.4%32.8%23.2%10.8%33.0%178.8%5.9%2020-102020-202020302020402021-102021202021.302021.402022102022202022302022402023-1Q2834004359.124058.084140583928.69244888657188823768841.159512.894895410440.7211172.7714.87%54.37%41.74%49.04%112.08%113.44%113.10%125.18%2.90%9.38%1833%28.37%981%65.46%2.08%5.17%135.44%1.92%020%759%-045%1026%7.01%1857.522845.57232482840322318873173.194548255583895884.048349.836372.718809.27787.0337.039%39.31%42.89%3823%40.95%6568%47.49%38.72%33.67%3325%32.70%34.78%30.30%292.72378.6271.944472858799785.9047.8244.7249.0557.11718399.372.0799.83104.149829798547.45114.93101.123122822883219.77213.98387134.1137.5920.9730.3519.542.177.03-0.110.426.45629.151150.821129.9985411109.975293.403470.752125852269292104.58214239222.12239887613.381150.071129.121101255277.093448902105822090.152129.442235.4423922997.0216188155.07138.77163.08724.61533.9430088340.222838925130303.6038028974.05822.73g38.184552472912.981804.941922.781808.281878.141931842032.02285%5323%58.13%36.33%380.89%199.0%11938%104.95%35.52%703%19.80%22.87%24.01%19.87%4924%3365%21.75%1899%1983%18.50%18.19%来源:公司公告,请务必阅读正文之后的重要声明部分